I'll address each question in turn.
In terms of jurisdiction, in a federated state I think each level of government has a role to play, and certainly for the federal government's role in terms of coordination, access to vaccine, antivirals, etc., I think that's very important. The delivery of public health is fundamentally a local activity. It needs to be coordinated at each level and the local jurisdictions are in the best position to actually do that.
We can facilitate and have certainly facilitated the sharing of information and of lessons learned, so that we've seen a major improvement in the clinics as we've moved forward. I'm not sure there's a jurisdictional issue there, since we're working well together.
In terms of vaccine and squalene, squalene itself is basically a fish oil with water and vitamin E. Other than increasing the risk of local side effects, we're not really seeing anything major related to the adjuvant other than the improvement of immunity, greater cross-protection, and a lower dose of the actual antigen being required.
In terms of antivirals as well as the medications in ICUs and in hospitals, hospitals in health regions across the country have been adding to their stockpiles, given the recognition in the spring of the kinds of medications that we need for these patients given the complexity of their disease, which they don't typically see with influenza. Some of the medications they would not normally use as much of, they went through very quickly, particularly in Manitoba, which was very hard hit. Each jurisdiction has added to its stockpiles of those.
As well, we have added them to the national emergency stockpile, with backup to the provinces and territories. We should be in a good position going forward. As we're now seeing 25% to 30% of the general population having been immunized, as well as much higher rates in the north and remote communities, rates of 50% to 60% or more, we should be getting well ahead of this over the next month.